SEARCH

SEARCH BY CITATION

FilenameFormatSizeDescription
bjh12384-sup-0001-FigS1.epsimage/eps626KFig S1. In vivo reduction of JAK2V617F allelic burden following treatment with panobinostat in patients with MF.
bjh12384-sup-0002-TableS1-3.docxWord document36KTable SI. Summary of the myelofibrosis symptom assessment form scores at baseline. Table SII. Reasons for patient discontinuation. Table SIII. Splenic reduction in patients with splenomegaly.

Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.